Prediction of the effect of dapagliflozin on kidney and heart failure outcomes based on short-term changes in multiple risk markers. [electronic resource]
Producer: 20210203Description: 1570-1576 p. digitalISSN:- 1460-2385
- Aged
- Albuminuria -- blood
- Benzhydryl Compounds -- therapeutic use
- Biomarkers -- blood
- Clinical Trials, Phase III as Topic
- Diabetes Mellitus, Type 2 -- drug therapy
- Diabetic Nephropathies -- blood
- Female
- Glucosides -- therapeutic use
- Heart Failure -- blood
- Humans
- Male
- Middle Aged
- Sodium-Glucose Transporter 2 Inhibitors -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.